It has been shown that there is a favorable trend in overall survival with platinum-based therapies in patients with HRR.
← all excerpts
<i>BRCA 1/BRCA 2</i> Pathogenic/Likely Pathogenic Variant Patients with Breast, Ovarian, and Other Cancers.
1
—
—